This is the authors' abstract. We don't add key points for this paper.
The bioorthogonal reaction between [1,2,4,5] tetrazines with trans ‐cyclooctene through the inverse electron demand Diels‐Alder (IEDDA) has been described as powerful bioconjugation tool. In this work, we explore the IEDDA as a modular conjugation strategy for in vitro and in vivo labeling of Rituximab for the generation of radioactive and fluorescently label immunoconjugates. The strategy allowed the generation, in vitro and in vivo , of conjugated Rituximab with cyanine 5 and 7 and the gamma emmiter technetium‐99m.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
García et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: